Literature DB >> 10853013

Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells.

C Page1, M Huang, X Jin, K Cho, J Lilja, R K Reynolds, J Lin.   

Abstract

We examined whether the persistent activation of AKT or Stat3 oncogene product is present in prostate, breast, and cervical cancer cells. We found that some prostate and breast cancer cell lines express high levels of phosphorylated AKT. Interestingly, the cancer cells, which only express low levels of phosphorylated AKT express high levels of phosphorylated Stat3. AKT or Stat3 is also highly phosphorylated in human papilloma virus-negative cervical cancer cells. Therefore, these results indicate that AKT and Stat3 are highly phosphorylated in some breast, prostate and cervical cancer cells, which may play a role in tumorigenesis of these cancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853013     DOI: 10.3892/ijo.17.1.23

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

Review 1.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.

Authors:  Zhenbing You; Dafu Xu; Jian Ji; Wei Guo; Weiguo Zhu; Jingdong He
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 3.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

4.  15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.

Authors:  Tyvette S Hilliard; Gabriella Miklossy; Christopher Chock; Peibin Yue; Philip Williams; James Turkson
Journal:  Mol Cancer Ther       Date:  2017-01-09       Impact factor: 6.261

5.  Expression of Stat3 in feline mammary gland tumours and its relation to histological grade.

Authors:  C Petterino; A Ratto; E Arcicasa; G Podestà; M Drigo; C Pellegrino
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

6.  Preliminary evaluation of safety of conditionally replication adenovirus M4.

Authors:  Caihong Chen; Haiyan Fang; Yumei Rao; Peng Wu; Yang He; Ding Ma; Qinglei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

7.  LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.

Authors:  Ja Eun Kim; Hong Sook Kim; Yong Jae Shin; Chang Seok Lee; Cheolhee Won; Sin Ae Lee; Jung Weon Lee; Youngsoo Kim; Jae Seung Kang; Sang Kyu Ye; Myung Hee Chung
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

Review 8.  The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.

Authors:  Jessica L Geiger; Jennifer R Grandis; Julie E Bauman
Journal:  Oral Oncol       Date:  2015-12-28       Impact factor: 5.337

9.  Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population.

Authors:  R C Sobti; Neha Singh; Showket Hussain; Vanita Suri; A C Bharti; B C Das
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

10.  In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa.

Authors:  Yue-mei Jin; Tian-min Xu; Yan-hui Zhao; Yi-chao Wang; Man-hua Cui
Journal:  Tumour Biol       Date:  2013-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.